Recent Updates
Recently added Catalysts
QTI Positive Sentiment

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

Tuesday, July 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QT Imaging Holdings, Inc. has received regulatory registration from the Israeli Ministry of Health for its innovative, radiation-free breast imaging scanner. This approval authorizes the company to commercialize the system in Israel until February 2, 2028. The registration is supported by the company's existing clearance from the U.S. FDA.
Price reaction · baseline $2.71 (2026-07-27 close) · hit pre-market · 1 other QTI headline(s) in the window, move may be shared
day 0 close
-2.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • QT Imaging's scanner has received regulatory registration in Israel.
  • The approval allows for commercialization of the system until February 2028.
  • The registration is based on existing U.S. FDA clearance.

Full Press Release Details

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Israeli Ministry of Health has granted registration for the Company's scanner, authorizing commercialization of the system in Israel through February 2, 2028. The approval is based on the Company's existing U.S. FDA clearance and applica

Frequently Asked Questions

What regulatory approval did QT Imaging receive?

QT Imaging received registration from the Israeli Ministry of Health.

How long is the registration valid for QT Imaging's scanner?

The registration is valid until February 2, 2028.

What is the basis for the Israeli approval?

The approval is based on QT Imaging's existing U.S. FDA clearance.

What type of technology does QT Imaging use?

QT Imaging utilizes innovative, radiation-free imaging technology.

ShareAdd on Google
Tags: QTI Viatris Investor Conferences Healthcare QT Imaging Israeli Ministry of Health breast imaging FDA clearance medical device
Last updated: Jul 28, 2026

Biotech snapshot

Cash runway
$11M liquidity · $2M/mo burn
~6 mo
High dilution risk